Nanostructured Cubosomes in Nasal Gels: Revolutionizing Brain Delivery for Migraine Management.

Migraine is a common neurological disorder that causes severe headaches. It significantly affects people's quality of life. Current treatments struggle to deliver drugs effectively to the brain. They also often cause side effects due to the Blood-Brain Barrier (BBB). A promising solution is nasal drug delivery, which avoids the BBB. Cubosomes are special lipid-based nanocarriers that can help with this. They have unique cubic structures and are biocompatible. These cubosomes can hold different types of drugs, both water-soluble and fat-soluble. Researchers conducted a thorough search for studies on cubosome-based nasal gels. They looked at intranasal delivery and the effectiveness of these gels for migraine therapy. The findings suggest that cubosomes could revolutionize how we treat migraines. This new method could improve drug delivery and reduce side effects for patients suffering from migraines. Clinical relevance: This research highlights the potential of cubosomes in nasal gels for effective migraine treatment, improving drug delivery while minimizing side effects for patients.